Focus on Baseline LDL-C and Patient Risk, Not Drug Type: A Perspective on Alirocumab vs Evolocumab.
Saved in:
| Title: | Focus on Baseline LDL-C and Patient Risk, Not Drug Type: A Perspective on Alirocumab vs Evolocumab. |
|---|---|
| Authors: | Sabouret P; Department of Cardiology, Sorbonne University, 75013 Paris, France., Giamundo DM; Department of Systems Medicine, 'Tor Vergata' University, 00133 Rome, Italy., Mamas M; Department of Cardiology, Royal Stoke University Hospital, University Hospitals of North Midlands NHS Trust, ST4 6QG Stoke-on-Trent, UK.; Keele Cardiovascular Research Group, Centre for Prognosis Research, Keele University, ST5 5BG Keele, UK. |
| Source: | Reviews in cardiovascular medicine [Rev Cardiovasc Med] 2026 Apr 21; Vol. 27 (4), pp. 50430. Date of Electronic Publication: 2026 Apr 21 (Print Publication: 2026). |
| Publication Type: | Editorial |
| Journal Info: | Publisher: IMR Press Country of Publication: Singapore NLM ID: 100960007 Publication Model: eCollection Cited Medium: Internet ISSN: 2153-8174 (Electronic) Linking ISSN: 15306550 NLM ISO Abbreviation: Rev Cardiovasc Med Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42110156 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Focus on Baseline LDL-C and Patient Risk, Not Drug Type: A Perspective on Alirocumab vs Evolocumab. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sabouret+P%22">Sabouret P</searchLink>; Department of Cardiology, Sorbonne University, 75013 Paris, France.<br /><searchLink fieldCode="AU" term="%22Giamundo+DM%22">Giamundo DM</searchLink>; Department of Systems Medicine, 'Tor Vergata' University, 00133 Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Mamas+M%22">Mamas M</searchLink>; Department of Cardiology, Royal Stoke University Hospital, University Hospitals of North Midlands NHS Trust, ST4 6QG Stoke-on-Trent, UK.; Keele Cardiovascular Research Group, Centre for Prognosis Research, Keele University, ST5 5BG Keele, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100960007%22">Reviews in cardiovascular medicine</searchLink> [Rev Cardiovasc Med] 2026 Apr 21; Vol. 27 (4), pp. 50430. <i>Date of Electronic Publication: </i>2026 Apr 21 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Editorial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22IMR+Press%22">IMR Press </searchLink><i>Country of Publication: </i>Singapore <i>NLM ID: </i>100960007 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2153-8174 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215306550%22">15306550 </searchLink><i>NLM ISO Abbreviation: </i>Rev Cardiovasc Med <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42110156 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.31083/RCM50430 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 50430 Titles: – TitleFull: Focus on Baseline LDL-C and Patient Risk, Not Drug Type: A Perspective on Alirocumab vs Evolocumab. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sabouret P – PersonEntity: Name: NameFull: Giamundo DM – PersonEntity: Name: NameFull: Mamas M IsPartOfRelationships: – BibEntity: Dates: – D: 21 M: 04 Text: 2026 Apr 21 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2153-8174 Numbering: – Type: volume Value: 27 – Type: issue Value: 4 Titles: – TitleFull: Reviews in cardiovascular medicine Type: main |
| ResultId | 1 |
